Patents by Inventor Kersten Walter

Kersten Walter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6419959
    Abstract: A pharmaceutical composition for oral administration contains naloxone-, N-methylnaloxone- and/or N-methylnaltrexone-containing particles which release the active substance depending on the ambient pH. This ensures the liberation of the active substance over the whole gastrointestinal tract. The side effects caused by the use of analgesic opioids, such as constipation, are thus eliminated without reducing the analgesic effect.
    Type: Grant
    Filed: August 10, 1999
    Date of Patent: July 16, 2002
    Assignee: Klinge Pharma GmbH
    Inventors: Kersten Walter, Thomas Profitlich
  • Patent number: 5698216
    Abstract: A transdermal therapeutic system for the administration of physostigmine to the skin, consisting of a backing layer impermeable to active substance, a pressure-sensitive reservoir layer containing 40 to 90%-wt. polymeric material and 0.1 to 20%-wt. physostigmine base or one of the pharmaceutically acceptable salts thereof, and of a detachable protective layer covering the reservoir layer, comprises in its reservoir layer acrylate- and/or methacrylate-based polymeric material and 0.1 to 40%-wt. of a softener containing the hydroxyl group with an HLB value between 1.1 and 12.0.
    Type: Grant
    Filed: July 12, 1995
    Date of Patent: December 16, 1997
    Assignee: LTS Lohmann Therapie-Systeme GmbH & Co.
    Inventors: Lothar Deurer, Thomas Hille, Thomas Profitlich, Fritz Stanislaus, Kersten Walter